Health-related quality of life outcomes between non-steroid and steroid aromatase inhibitors and switching hormone therapy in postmenopausal women with ER+ breast cancer

Health-related quality of life outcomes between non-steroid and steroid aromatase inhibitors and switching hormone therapy in postmenopausal women with ER+ breast cancer

Adjuvant hormone therapy can affect the quality of life of postmenopausal breast cancer patients with the estrogen receptor (ER+). This study aimed to measure the outcomes of health-related quality of life (HRQoL) in postmenopausal women with ER+ breast cancer receiving non-steroidal aromatase inhib...

Full description

Saved in:
Bibliographic Details
Main Authors: Wawang Anwarudin, Ajeng Diantini, Melisa I. Barliana, Auliya A. Suwantika
Format: Article
Language:English
Published: Pensoft Publishers 2024-12-01
Series:Pharmacia
Online Access:https://pharmacia.pensoft.net/article/135324/download/pdf/
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items